Logo image of CREV

CARBON REVOLUTION PLC (CREV) Stock Fundamental Analysis

NASDAQ:CREV - Nasdaq - IE000OD0CSK4 - Common Stock - Currency: USD

2.79  -0.31 (-10%)

Fundamental Rating

1

Taking everything into account, CREV scores 1 out of 10 in our fundamental rating. CREV was compared to 81 industry peers in the Automobile Components industry. CREV may be in some trouble as it scores bad on both profitability and health. CREV is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

CREV had negative earnings in the past year.
CREV had a negative operating cash flow in the past year.
CREV Yearly Net Income VS EBIT VS OCF VS FCFCREV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 2M -2M 4M 6M

1.2 Ratios

Looking at the Return On Assets, with a value of -3.65%, CREV is doing worse than 85.19% of the companies in the same industry.
The Return On Equity of CREV (-4.38%) is worse than 77.78% of its industry peers.
Industry RankSector Rank
ROA -3.65%
ROE -4.38%
ROIC N/A
ROA(3y)2.89%
ROA(5y)N/A
ROE(3y)3.02%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CREV Yearly ROA, ROE, ROICCREV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 1 -1 2 3

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for CREV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CREV Yearly Profit, Operating, Gross MarginsCREV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023

More info and screens

2

2. Health

2.1 Basic Checks

The number of shares outstanding for CREV remains at a similar level compared to 1 year ago.
There is no outstanding debt for CREV. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CREV Yearly Shares OutstandingCREV Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 5M 10M 15M 20M 25M
CREV Yearly Total Debt VS Total AssetsCREV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

Based on the Altman-Z score of -0.30, we must say that CREV is in the distress zone and has some risk of bankruptcy.
CREV's Altman-Z score of -0.30 is on the low side compared to the rest of the industry. CREV is outperformed by 90.12% of its industry peers.
CREV has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
CREV's Debt to Equity ratio of 0.02 is amongst the best of the industry. CREV outperforms 91.36% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z -0.3
ROIC/WACCN/A
WACCN/A
CREV Yearly LT Debt VS Equity VS FCFCREV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 0.01 indicates that CREV may have some problems paying its short term obligations.
With a Current ratio value of 0.01, CREV is not doing good in the industry: 98.77% of the companies in the same industry are doing better.
CREV has a Quick Ratio of 0.01. This is a bad value and indicates that CREV is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.01, CREV is doing worse than 98.77% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.01
Quick Ratio 0.01
CREV Yearly Current Assets VS Current LiabilitesCREV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 1M 2M 3M 4M

More info and screens

0

3. Growth

3.1 Past

CREV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -368.49%.
EPS 1Y (TTM)-368.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3282.35%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, CREV will show a very negative growth in Earnings Per Share. The EPS will decrease by -610.37% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-15164.67%
EPS Next 2Y-610.37%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CREV Yearly Revenue VS EstimatesCREV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 2025 20M 40M 60M 80M 100M
CREV Yearly EPS VS EstimatesCREV Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 -5 -10 -15 -20

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

CREV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CREV. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CREV Price Earnings VS Forward Price EarningsCREV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CREV Per share dataCREV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

CREV's earnings are expected to decrease with -610.37% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-610.37%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CREV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CARBON REVOLUTION PLC

NASDAQ:CREV (5/6/2025, 8:00:30 PM)

2.79

-0.31 (-10%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners3.58%
Inst Owner ChangeN/A
Ins Owners9.57%
Ins Owner ChangeN/A
Market Cap5.25M
Analysts82.86
Price Target39.78 (1325.81%)
Short Float %0.54%
Short Ratio0.3
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.14
P/tB 0.14
EV/EBITDA N/A
EPS(TTM)-0.14
EYN/A
EPS(NY)-4.86
Fwd EYN/A
FCF(TTM)-0.38
FCFYN/A
OCF(TTM)-0.38
OCFYN/A
SpS0
BVpS19.25
TBVpS19.25
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.65%
ROE -4.38%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)2.89%
ROA(5y)N/A
ROE(3y)3.02%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.01
Quick Ratio 0.01
Altman-Z -0.3
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-368.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3282.35%
EPS Next Y-15164.67%
EPS Next 2Y-610.37%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-24.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-728.01%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-53.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-53.84%
OCF growth 3YN/A
OCF growth 5YN/A